Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Overview of treatment of female infertility

INTRODUCTION

Infertility is a complex disorder with significant medical, psychosocial, and economic aspects [1]. Great strides have been achieved in infertility therapy, with new and effective treatments available in the field of assisted reproductive technology (ART).

Once the cause of infertility is identified, therapy aimed at correcting reversible etiologies and overcoming irreversible factors can be implemented. The couple is also counseled on lifestyle modifications to improve fertility, such as smoking cessation, reducing excessive caffeine and alcohol consumption, and appropriate frequency of coitus (table 1). (See "Optimizing natural fertility in couples planning pregnancy".)

Further research on causes of infertility and therapeutic modalities is needed to improve the overall success of female infertility treatment. Reducing the cost of therapy, the risk of multiple gestation, and complications such as ovarian hyperstimulation will improve patient access to, and the safety of, infertility therapy.

An overview of the treatment of female infertility is provided here. The evaluation of female infertility, as well as the causes and treatment of male infertility, are discussed separately:
To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Benyamini, Y, Gozlan, M, Kokia, E. Variability in the difficulties experienced by women undergoing infertility treatments. Fertil Steril 2005; 83:275.
  2. Collins, JA, Wrixon, W, Janes, LB, Wilson, EH. Treatment-independent pregnancy among infertile couples. N Engl J Med 1983; 309:1201.
  3. Frisch, RE. The right weight: body fat, menarche and ovulation. Baillieres Clin Obstet Gynaecol 1990; 4:419.
  4. Kiddy, DS, Hamilton-Fairley, D, Bush, A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36:105.
  5. Pasquali, R, Antenucci, D, Casimirri, F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68:173.
  6. Clark, AM, Ledger, W, Galletly, C, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10:2705.
  7. Crosignani, PG, Colombo, M, Vegetti, W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003; 18:1928.
  8. Guzick, DS, Wing, R, Smith, D, et al. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994; 61:598.
  9. Snow, RC, Barbieri, RL, Frisch, RE. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen. J Clin Endocrinol Metab 1989; 69:369.
  10. Reifenstein, EC Jr. Psychogenic or "hypothalamic" amenorrhea. Med Clin North Am 1946; 30:1103.
  11. Yen, SS, Rebar, R, Vandenberg, G, et al. Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis. J Reprod Fertil Suppl 1973; 20:137.
  12. Crowley, WF Jr, Filicori, M, Spratt, D, et al. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985; 41:473.
  13. Berga, SL, Girton, LG. The psychoneuroendocrinology of functional hypothalamic amenorrhea. Psychiatr Clin North Am 1989; 12:105.
  14. Laughlin, GA, Dominguez, CE, Yen, SSC. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998; 83:25.
  15. Reame, NE, Sauder, SE, Case, GD, et al. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: Evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab 1985; 61:851.
  16. Berga, SL, Marcus, MD, Loucks, TL, et al. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy. Fertil Steril 2003; 80:976.
  17. Abraham, S, Mira, M, Llewellyn-Jones, D. Should ovulation be induced in women recovering from an eating disorder or who are compulsive exercisers?. Fertil Steril 1990; 53:566.
  18. Steiner, AZ, Terplan, M, Paulson, RJ. Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod 2005; 20:1511.
  19. Oktay, K, Buyuk, E, Davis, O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18:90.
  20. Oktay, K, Buyuk, E, Davis, O, Veeck, L, Rosenwaks, Z. A prospective comparison of tamoxifen alone and tamoxifen-FSH combined protocol for IVF and fertility preservation in breast cancer patients. Fertil Steril 2003; 80:S63.
  21. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89:505.
  22. Farquhar, C, Vandekerckhove, P, Lilford, R. Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2001; :CD001122.
  23. Honore, GM, Holden, AE, Schenken, RS. Pathophysiology and management of proximal tubal blockage. Fertil Steril 1999; 71:785.
  24. Johnson, NP, Mak, W, Sowter, MC. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2004; :CD002125.
  25. Heinonen, PK, Saarikoski, S, Pystynen, P. Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand 1982; 61:157.
  26. March, CM, Israel, R. Gestational outcome following hysteroscopic lysis of adhesions. Fertil Steril 1981; 36:455.
  27. Perez-Medina, T, Bajo-Arenas, J, Salazar, F, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod 2005; 20:1632.
  28. Coutifaris, C, Myers, ER, Guzick, DS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004; 82:1264.
  29. Helmerhorst, F, Van Vliet, H, Gornas, T, et al. Intra-uterine insemination versus timed intercourse for cervical hostility in subfertile couples. Cochrane Database Syst Rev 2005; 4:CD002809.
  30. Check, JH, Adelson, HG, Wu, CH. Improvement of cervical factor with guaifenesin. Fertil Steril 1982; 37:707.
white circle LOG IN
white circle DEMO